Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 8 of 8 for “"Peripheral ischemia"”.
-
Development of advanced treatment strategies for peripheral ischemia
Peripheral vascular disease has become a prevalent condition worldwide and its incidence is predicted to increase as the median age of the population rises. In patients with severe peripheral ischemia, surgical or percutaneous interventions are necessary, but these procedures are invasive and …
-
Die zentrale und periphere venoarterielle extracorporale Membranoxygenierung bei Patienten im kardiogenen Schock
… p = 0.023). Stroke rates, renal failure, and peripheral ischemia were similar. Weaning rate from ECMO (52.9% vs. 52.3%, p = NS) was similar. The 30 day mortality was higher in group P (60% vs. 76.1%, p = 0.029). Central cannulation for VA-ECMO provides antegrade flow without Harlequin's …
-
Insights into the mechanisms of Remote Ischemic Preconditioning
Short repeated cycles of peripheral Ischemia/Reperfusion (I/R) can protect remote organs (e.g. heart) from subsequent prolonged I/R injury; a phenomenon known as Remote Ischemic Preconditioning (RIPC). A RIPC-mediated release of humoral factors might play a key role in this protection and vascular …
-
Syndesomes for enhanced wound healing and therapeutic angiogenesis in a diabetic diseased state
Peripheral vascular disease (PVD) affects more than 202 million people globally and about 20% of the population above 65 years of age in the United States alone. Type-2 diabetes afflicts around 347 million people worldwide and leads to the death of 4.6 million people. The rising prevalence of …
-
Targeting Vascular Tissue Factor Expression: Pathophysiology and Clinical Implications
… unstable angina pectoris, myocardial infarction, peripheral ischemia, and stroke. The fate of a forming thrombus is determined by the balance between pro-thrombotic mediators such as tissue factor (TF) and plasminogen activator inhibitor type 1 (PAI- 1), and anti-thrombotic factors like tissue …
-
Oxygen-nanobubble biotechnology to enhance physiologic wound healing and tissue regeneration in vivo
… in systemic vasculopathies predisposing to peripheral ischemia, tissue hypoxia, and suboptimal healing, such as diabetes mellitus, the aging world population, and the questionable capacity of the available management and prevention strategies to confront a potentially generalized surge in …
-
Thromboelastography in the assessment of coagulation changes in peripheral vascular disease
… changes in coagulation in patients with peripheral vascular disease(PVD) have consistently reported activation of coagulation based on measurement of raised levels of markers of activation of coagulation(clot formation), decreased fibrinolysis (breakdown of fibrin), platelet activation …
-
Μελέτη της θεραπευτικής επίδρασης της σιλοσταζόλης στη φλεγμονώδη απόκριση και την εξέλιξη της ισχαιμίας άκρου σε μύες
… and extracellular adenosine uptake. Using a Peripheral Arterial Disease (PAD) mouse model, the purpose of this study was to investigate the revascularization of ischemic muscles after the induction of surgical hind limb ischemia, as well as the interactions between cilostazol and innate …